InMed Pharmaceuticals INM
NASDAQ INM
$1.33 -0.02 (-1.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Income from Discontinued Operations (2025 - 2026)

Updated

InMed Pharmaceuticals (INM) recorded Income from Discontinued Operations of -$996,330 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $46,305 a year earlier.

Analysis

InMed Pharmaceuticals (INM) Income from Discontinued Operations (2025 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), InMed Pharmaceuticals reported Income from Discontinued Operations of -$1.19 million.

  • Across earlier fiscal years, Income from Discontinued Operations came in at $528,175 in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Linde 221.03 Bn 204.14 Bn 4.43 Bn -
2 Corning 141.47 Bn 134.60 Bn 1.63 Bn -
3 Sherwin Williams 77.59 Bn 76.63 Bn 3.34 Bn -
4 Air Products & Chemicals 61.84 Bn 59.74 Bn 1.04 Bn -
5 LyondellBasell Industries 37.84 Bn 27.46 Bn 2.04 Bn -13.00 Mn
6 Nutrien 33.77 Bn 30.64 Bn 3.25 Bn -
7 Qnity Electronics 27.51 Bn 24.93 Bn 666.00 Mn -
8 Ati 26.21 Bn 24.36 Bn 309.80 Mn -
9 Ppg Industries 23.37 Bn 16.17 Bn 1.81 Bn -2.00 Mn
10 InMed Pharmaceuticals 5.54 Mn 3.34 Mn - -996,330.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -996,330.00
Mar 31, 2026 -174,585.00
Jun 30, 2025 46,305.00
Mar 31, 2025 -53,861.00
API Access

InMed Pharmaceuticals Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=INM&period=max&api_key=YOUR_API_KEY